What are the effects of angiotensin-converting-enzyme inhibitors on cardiovascular events in high-risk patients?
The Heart Outcomes Prevention Evaluation Study Investigators conducted a study to examine the effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. According to the study, ramipril was found to be effective in reducing the risk of cardiovascular events in high-risk patients. Other studies have also examined the effects of angiotensin-converting-enzyme inhibitors such as irbesartan and losartan on the development of diabetic nephropathy in patients with type 2 diabetes. These studies have found that these medications can be effective in reducing the risk of developing nephropathy in patients with type 2 diabetes.